Changeflow GovPing Trade Procurement NIH Notice of Change to PAR-24-272 Award Inform...
Routine Notice Amended Final

NIH Notice of Change to PAR-24-272 Award Information

Favicon for grants.nih.gov NIH Guide Funding Opportunities
Published March 4th, 2026
Detected March 5th, 2026
Email

Summary

The National Institutes of Health (NIH) issued a notice to update award information for PAR-24-272, the Clinical and Translational Science Award. The notice specifies changes to eligible receipt dates and adjusts budget tiers based on updated NIH funding data for fiscal years 2020-2024.

What changed

The National Center for Advancing Translational Sciences (NCATS) has issued a notice (NOT-TR-26-003) amending the award information for Funding Opportunity Announcement PAR-24-272, concerning the Clinical and Translational Science Award (UM1). The primary changes affect the eligible receipt dates, now set for May 28, 2026, and September 28, 2026. Additionally, the maximum direct cost budget requests for UM1 awards have been revised, with updated thresholds for different Hub Tiers based on NIH funding data from FY2020-FY2024, rather than the previous FY2019-FY2023 data.

Potential applicants and current awardees should review the updated award budget section to understand the new eligibility criteria and funding tiers for the specified receipt dates. While this notice clarifies budget information and receipt dates, all other aspects of the original PAR-24-272 announcement remain unchanged. No new compliance actions are immediately required beyond ensuring awareness of these modifications for upcoming application cycles.

What to do next

  1. Review updated award budget tiers and receipt dates for PAR-24-272
  2. Note changes in maximum direct cost budget requests based on FY2020-FY2024 NIH funding data

Source document (simplified)

Notice of Change to PAR-24-272 Clinical and Translational Science Award (UM1 Clinical Trial Optional) in Award Information Notice Number: NOT-TR-26-003

Key Dates

Release Date: March 04, 2026

Related Announcements

  • September 04, 2024 - Clinical and Translational Science Award (UM1 Clinical Trial Optional). See NOFO PAR-24-272.

Issued by

National Center for Advancing Translational Sciences (NCATS)

Purpose

The purpose of this Notice is to inform potential applicants of the changes in the Award Information for PAR-24-272 Clinical and Translational Science Award (UM1 Clinical Trial Optional) for receipt dates of May 28, 2026 and September 28, 2026. Changes to the table in the Award Budget section of the NOFO include specifying the applicable receipt dates (May 28, 2026 and September 28, 2026), an update under the heading “Maximum Direct Cost Budget Requests for UM1” to indicate amounts listed are based on FY2020-FY2024 NIH funding data and which amounts are applicable to each corresponding Hub Tier. All changes are indicated in bold italics under the “Revised to Read” section of this Notice.

Section II. Award Information

Award Budget

Currently Reads:

The amount of funding that applicants can request depends on the amount of NIH funding they receive. After calculating the total amount of NIH funding received as described in Section IV. Application and Submission Information, 2. Content and Form of Application Submission, R&R Budget, applicants may request the following amounts:

| Size Eligibility Budget Tiers for NOFO Applicants
(NOFO receipt dates March 13, 2025, May 28, 2025, September 29, 2025) | Maximum Direct Cost Budget Requests for UM1 | |
| Hub Tier | 5-year average of the most current NIH Direct Cost (DC) Funding of the applicant institution, PLUS 5-year average of the most current NIH Direct Cost (DC) of any partner(s)*

(based on FY2019-FY2023 NIH Funding data) | UM1 |
| A | >$385,000,000 | $6,500,000 |
| C | $250,000,000 - $384,999,999 | $5,000,000 |
| T | $175,000,000 - $249,999,999 | $3,600,000 |
| G | <$174,999,999 | $2,600,000 |

Revised to Read:

Award Budget

The amount of funding that applicants can request depends on the amount of NIH funding they receive. After calculating the total amount of NIH funding received as described in Section IV. Application and Submission Information, 2. Content and Form of Application Submission, R&R Budget, applicants may request the following amounts:

| Size Eligibility Budget Tiers for NOFO Applicants
(NOFO receipt dates May 28, 2026, September 28, 2026) | Maximum Direct Cost Budget Requests for UM1 | |
| Hub Tier | 5-year average of the most current NIH Direct Cost (DC) Funding of the applicant institution, PLUS 5-year average of the most current NIH Direct Cost (DC) of any partner(s)*

(based on *FY2020-FY2024** NIH Funding data)* | UM1 |
| A | >$400,000,000 | $6,500,000 |
| C | $265,000,000 - $399,999,999 | $5,000,000 |
| T | $190,000,000 - $264,999,999 | $3,600,000 |
| G | <$189,999,999 | $2,600,000 |

All other aspects of the Notice of Funding Opportunity Announcement remain unchanged.

Inquiries

Please direct all inquiries to:

National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-402-0264
Email: [email protected]

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices Department of Health
and Human Services (HHS) NIH... Turning Discovery Into Health ®

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
Various Federal Agencies
Published
March 4th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Substantive

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies Healthcare providers
Geographic scope
National (US)

Taxonomy

Primary area
Education
Operational domain
Compliance
Topics
Clinical Trials Funding Opportunities

Get Trade Procurement alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when NIH Guide Funding Opportunities publishes new changes.

Free. Unsubscribe anytime.